Lucy June Sloan

Dr. Lucy June Sloan

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 August 2022 in Biomedicines
Verified
Journal Article
Open access
PDF file
HHHeeJue Hong
HeeJue Hong
LSLucy June Sloan
Lucy June Sloan
DSDeepak Saxena
Deepak Saxena
DSDavid A. Scott
David A. Scott
Cannabinoid receptor 2 (CB2) is of interest as a much-needed target for the treatment or prevention of several neurogenerative diseases. However, CB2 agonists, particularly phytocannabinoids, have been ascribed antimicrobial properties and are associated with the induction of microbiome compositional fluxes. When developing novel CB2 therapeutics, CB2 engagement and antimicrobial functions should both be considered. This review summarizes those cannabinoids and cannabis-informed molecules and preparations (CIMPs) that show promise as microbicidal agents, with a particular focus on the most recent developments. CIMP–microbe interactions and anti-microbial mechanisms are discussed, while the major knowledge gaps and barriers to translation are presented. Further research into CIMPs may proffer novel direct or adjunctive strategies to augment the currently available antimicrobial armory. The clinical promise of CIMPs as antimicrobials, however, remains unrealized. Nevertheless, the microbicidal effects ascribed to several CB2 receptor-agonists should be considered when designing therapeutic approaches for neurocognitive and other disorders, particularly in cases where such regimens are to be long-term. To this end, the potential development of CB2 agonists lacking antimicrobial properties is also discussed.

30 October 2025 in Biomolecules
Verified
Journal Article
Open access
PDF file
DZDandan Zhao
Dandan Zhao
VMVishaka Motheramgari
Vishaka Motheramgari
RFRiley Freudenberger
Riley Freudenberger
SSSarah H. Shrader
Sarah H. Shrader
LSLucy June Sloan
Lucy June Sloan
Zhao-Hui SongZhao-Hui Song
Zhao-Hui Song
Aberrant wound healing in the retina can manifest as proliferative vitreoretinopathy (PVR), which involves the myofibroblast transdifferentiation of retinal pigment epithelial (RPE) cells. In this study, experiments were conducted to examine the structure–activity relationships of endocannabinoid-like compounds, N-acyl dopamines, on the myofibroblast transdifferentiation of RPE cells. The collagen matrix contraction assay was used to assess myofibroblast function. Western blot analysis and immunocytochemistry techniques were used to evaluate myofibroblast markers. N-palmitoyl dopamine (PALDA), N-oleoyl dopamine (OLDA), and N-arachidonoyl dopamine (NADA), in a concentration-dependent manner, inhibited contraction of collagen matrices mediated by either primary porcine RPE cells treated with TGF-β2, or human RPE cells treated with TGF-β2 plus TNFα (TNT). The rank order of potency was PLDA = OLDA > NADA. In contrast, the substitution of dopamine with other polar head groups led to a complete loss of their ability to inhibit myofibroblast transdifferentiation. Western blot analysis demonstrated that PALDA, OLDA, and NADA down-regulated the myofibroblast markers fibronectin and α-SMA. Immunocytochemistry experiments showed that these N-acyl dopamines reduced the incorporation of α-SMA into F-actin stress fibers. Overall, these structure–activity relationship studies demonstrate that the dopamine head group is crucial for N-acyl dopamine to inhibit myofibroblast transdifferentiation of RPE cell, whereas the fatty acid side chain determines the potency of it. This study points to the potential of N-acyl dopamines as a novel class of therapeutic agents for treating retinal fibrotic conditions, such as PVR.

1 December 2024 in Alzheimer's & Dementia
Verified
Journal Article
Open access
LSLucy June Sloan
Lucy June Sloan
PCPaula M. Chilton
Paula M. Chilton
ARAakarsha V. Rao
Aakarsha V. Rao
JZJingWen Zhang
JingWen Zhang
SMScott A. Myers
Scott A. Myers
SBShirish Barve
Shirish Barve
Background: Chronic, excessive alcohol consumption causes neurodegeneration and is associated with an increased risk for Alzheimer’s disease (AD) and other dementias. Moreover, there has been a consistent rise in alcohol consumption in older adults in the past few decades. However, there is minimal research showing how alcohol consumption affects AD neuropathogenesis and biological mechanisms remain unclear. We hypothesize that mid‐life chronic binge alcohol consumption accelerates AD neuropathology in the hippocampus, among the first brain regions affected by AD, through dysregulation of processes associated with AD pathogenesis.Methods: Female triple transgenic (3xTg; n = 15) mice and non‐transgenic (NonTg) control mice (B6.129; n = 13) were given EtOH binges twice/week (4g/kg) by oral gavage for 3.5 months (from 6‐9.5 months) while untreated controls (3xTg n = 6 and NonTg n = 4) received sham gavages. Memory was evaluated with the novel object recognition test (NORT). RNA was extracted from the mid‐brain region of one hemisphere for RNA‐Sequencing (Illumina NextSeq2000; STAR/HTSeq/DESeq2 pipeline) and qPCR, while protein lysates from the opposite hemisphere’s midbrain region was used for Western blot (WB) analyses. Plasma neurofilament light chain (NfL) was measured with a MesoScale Discovery kit.Results: One week after the final EtOH gavage, hippocampal‐dependent memory was significantly impaired in EtOH binged 3xTg mice, while NonTg mice were unaffected. Similarly, EtOH binge slightly increased plasma NfL in 3xTg mice, indicating persistent EtOH‐induced neurodegeneration, while nonTg mice showed a significant decrease. RNA‐seq from the mid‐brain region containing the hippocampus revealed that chronic EtOH binge significantly affected 8477 genes (4473 up‐ and 4004 down‐regulated) in 3xTg mice, while only 4 genes were significantly affected (2 up‐ and 2 down‐regulated) in nonTg mice. Enrichment analyses showed EtOH altered several processes associated with neurodegeneration in 3xTg mice including regulation of synaptic plasticity and autophagy.Conclusions: Results indicate that 3xTg mice are more sensitive to EtOH‐mediated effects on neurodegeneration and memory impairment than nonTg controls. There was also significant EtOH‐induced dysregulation of AD‐related processes in the mid‐brain of 3xTg mice, a region affected early by AD neuropathology. Together, these data show that chronic mid‐life EtOH binging accelerates early AD neuropathology in 3xTg mice.